High-Sensitivity Cardiac Troponins I and T and Cardiovascular Outcomes: Findings from the Systolic Blood Pressure Intervention Trial (SPRINT).
Xiaoming JiaVijay NambiJarett D BerryDjhenne DalmacySimon B AscherAddison A TaylorRon C HoogeveenJames A de LemosChristie M BallantynePublished in: Clinical chemistry (2023)
Baseline levels and change in hs-cTnI over 1 year identified higher-risk individuals who may derive greater cardiovascular benefit with intensive blood pressure treatment. hs-TnI and hs-TnT have complementary value in CVD risk assessment. ClinicalTrials.gov Registration Number: NCT01206062.